Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.65
-0.13 (-0.50%)
At close: Jul 11, 2025, 4:00 PM
25.66
+0.01 (0.04%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
145.83B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
Dec 31, 2014 | 78,300 | 600 | 0.77% |
Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
Dec 31, 2001 | 90,000 | 0 | - |
Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
Dec 31, 1994 | 40,800 | 300 | 0.74% |
Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PFE News
- 1 day ago - Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys - Seeking Alpha
- 2 days ago - 3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies - Seeking Alpha
- 2 days ago - Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win - Reuters
- 2 days ago - XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence - Business Wire
- 4 days ago - Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than others - CNBC
- 5 days ago - My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus - Seeking Alpha
- 5 days ago - Forget Get Rich Quick: The Real Dividend Strategy That Built My Income Machine - Seeking Alpha
- 7 days ago - 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025) - Seeking Alpha